Evaluation of 2 celecoxib derivatives: Analgesic effect and selectivity to cyclooxygenase-2/1

Acta Pharmacologica Sinica

Volumn 26, Issue 12, 2005, Pages 1505-1511

  Lu, Zhi Hong ^a   Xiong, Xiao Yun ^a   Zhang, Bang Le ^a   Lin, Guo Cheng ^a   Shi, Yu Xiang ^a   Liu, Zhen Guo ^a   Meng, Jing Ru ^a   Zhou, Yu Mei ^a   Mei, Qi Bing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Celecoxib; Cyclooxygenase inhibitors; Mice; Pain; Selectivity

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETIC ACID; ANALGESIC AGENT; CALCIMYCIN; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FORMALDEHYDE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG DOSE; FEMALE; HOT PLATE TEST; IC 50; MACROPHAGE; MOUSE; NONHUMAN; RADIOIMMUNOASSAY; SPINAL CORD; SUPERNATANT; TAIL FLICK TEST;

6-KETOPROSTAGLANDIN F1 ALPHA; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEMALE; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; NAPHTHALENES; PYRAZOLES; SULFONAMIDES;

EID: 29044433880     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00222.x     Document Type: Article

References (12)

1. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 1997; 24 Suppl 49: 15-9.
2. Lane JM. Anti-inflammatory medications: selective COX-2 inhibitors. J Am Acad Orthop Surg 2002; 10: 75-8.
3. Zhang BL, Mei QB, He W, Zhou SY. Synthesis of celecoxib. Chin J New Drug 2002; 11: 859-61.
4. Zhang BL, Mei QB, Zhou SY, He W, Chen CS. Quantitative structure-activity relationship of the 1, 5-diarylpyrazole class of cyclooxygenase-2 selective inhibitors. J Fourth Milit Med Univ 2003; 24: 1523-5.
5. Ewell RD, Spencer PS. Antinociceptive activity of narcotic agonist and partial agonist analgesics and other agents in the tail-immersion test in mice and rats. Neuropharmacology 1976; 15: 683-8.
6. Baker AK, Hoffmann VL, Meert TF. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain. Pharmacol Biochem Behav 2002; 74: 73-86.
7. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, et al. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 1995; 305: 479-84.
8. Brideau C, Kargman S, Liu S, Dallob AL, Ehrich EW, Rodger IW, et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res 1996; 45: 68-74.
9. Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 1997; 121: 105-17.
10. Lazer ES, Miao CK, Cywin CL, Sorcek R, Wong HC, Meng Z, et al. Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity. J Med Chem 1997; 40: 980-9.
11. Naraba H, Murakami M, Matsumoto H, Shimbara S, Ueno A, Kudo I, et al. Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J Immunol 1998; 160: 2974-82.
12. Shen F, Bai AP, Guo ZR, Cheng CF. Inhibitory effect of 3,4-diaryl-3-pyrrolin-2-one derivatives on cyclooxygenase 1 and 2 in murine peritoneal macrophages. Acta Pharmacol Sin 2002; 23: 762-8.